ConductScience.org, home

Paper29456015

Multi-antigenic human cytomegalovirus mRNA vaccines that elicit potent humoral and cell-mediated immunity.

John S and 6 others. Vaccine, 2018. Cited by 176 papers, by iCite.

Cite this record

ConductScience Library. Multi-antigenic human cytomegalovirus mRNA vaccines that elicit potent humoral and cell-mediated immunity. Papers, record 29456015. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29456015

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Multi-antigenic human cytomegalovirus mRNA vaccines that elicit potent humoral and cell-mediated immunity.
PubMed
Journal
Vaccine
PubMed
Year
2018
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
176
iCite
Relative citation ratio, by iCite
6.01
iCite
Revised in PubMed
2018-09-18
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1John SShinu
2Yuzhakov OOlga
3Woods AAngela
4Deterling JJessica
5Hassett KKimberly
6Shaw CAChristine A
7Ciaramella GGiuseppe

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CytomegalovirusMajor topic
Cytomegalovirus InfectionsMajor topic
Cytomegalovirus VaccinesMajor topic
Immunity, CellularMajor topic
Immunity, HumoralMajor topic
Vaccines, SyntheticMajor topic
Animals
Antibodies, Neutralizing
Antibodies, Viral
Cell Line
Cytokines
Female
Gene Expression
Humans
Mice
Neutralization Tests
T-Lymphocytes
Vaccination

Source PubMed

Download CSV of topics

Cited by140

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 176 citations.

PMIDTitleJournalYearIn PapersSource
42844249Bioengineering strategies for improving the immunogenicity of mRNA vaccines.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42844249PubMed
42460750Cancer Vaccine Development: Toward Artificial Intelligence-Assisted Personalized Cell Membrane Nanovaccine.Small2026https://conductscience.org/library/papers/42460750PubMed
42439560Functional dissection of HCMV gB's autonomous fusion activity provides insights into how polymorphisms in clinical isolates confer distinct characteristics.mBio2026https://conductscience.org/library/papers/42439560PubMed
42188814
Safety and Immunogenicity of the Cytomegalovirus Vaccine mRNA-1647 in Healthy Adults: Results from a Phase 2, Randomized, Controlled, Dose-Finding Trial with Long-Term Extension Follow-Up Through Month 48.
Vaccines (Basel)2026https://conductscience.org/library/papers/42188814PubMed
42081324Enhanced immunogenicity and dose-sparing efficacy of self-amplifying RNA vaccines against seasonal influenza across subtypes.Emerg Microbes Infect2026https://conductscience.org/library/papers/42081324PubMed
41962202Recent advances in LNP-mRNA vaccines.Colloids Surf B Biointerfaces2026https://conductscience.org/library/papers/41962202PubMed
41710557Pre-clinical evaluation of mRNA-lipid nanoparticles' potency and toxicity: current practices and future directions.In Vitro Model2025https://conductscience.org/library/papers/41710557PubMed
41600815Elements of Viral Outbreak Preparedness: Lessons, Strategies, and Future Directions.Viruses2025https://conductscience.org/library/papers/41600815PubMed
41285802mRNABERT: advancing mRNA sequence design with a universal language model and comprehensive dataset.Nat Commun2025https://conductscience.org/library/papers/41285802PubMed
41266455To generate functional anti-protease-activated receptor-4 (PAR4), a G protein-coupled receptor, antibodies through PAR4-mRNA-LNP immunization.NPJ Vaccines2025https://conductscience.org/library/papers/41266455PubMed
41179708mRNA Vaccines: Current Applications and Future Directions.MedComm (2020)2025https://conductscience.org/library/papers/41179708PubMed
41059491Design Strategies for Novel Lipid Nanoparticle for mRNA Vaccine and Therapeutics: Current Understandings and Future Perspectives.MedComm (2020)2025https://conductscience.org/library/papers/41059491PubMed
41020145Vaccines as Potential Frontliners Against Antimicrobial Resistance (AMR): A Focused Review.Infect Drug Resist2025https://conductscience.org/library/papers/41020145PubMed
40990374Specificity and functional humoral immune responses induced by the VBI-1501A eVLP HCMV gB vaccine compared to the gB/MF59 vaccine.Hum Vaccin Immunother2025https://conductscience.org/library/papers/40990374PubMed
40873637Exploring the Potential and Advancements of Circular RNA Therapeutics.Exploration (Beijing)2025https://conductscience.org/library/papers/40873637PubMed
40855125A modular vaccine platform for optimized lipid nanoparticle mRNA immunogenicity.Nat Biomed Eng2026https://conductscience.org/library/papers/40855125PubMed
40730746A novel nanoparticle vaccine displaying multistage tuberculosis antigens confers protection in mice infected with H37Rv.NPJ Vaccines2025https://conductscience.org/library/papers/40730746PubMed
40589473Enhancing nucleic acid delivery by the integration of artificial intelligence into lipid nanoparticle formulation.Front Med Technol2025https://conductscience.org/library/papers/40589473PubMed
40518670mRNA-LNP vaccines against hepatitis B virus induce protective immune responses in preventive and chronic mouse challenge models.Mol Ther2025https://conductscience.org/library/papers/40518670PubMed
40338082A human cytomegalovirus prefusion-like glycoprotein B subunit vaccine elicits humoral immunity similar to that of postfusion gB in mice.J Virol2025https://conductscience.org/library/papers/40338082PubMed

See all 140 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29456015

GET https://conductscience.org/api/papers/v1/29456015/cited_by?page=2